{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:50:34Z","timestamp":1788000634961,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ankara Ophthalmology Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the aqueous humor (AH) and the serum clusterin levels of patients with pseudoexfoliation syndrome (PEX), pseudoexfoliation glaucoma (PEXG), and primary open-angle glaucoma (POAG) with each other and with an age- and sex-matched control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective, cross-sectionalstudy evaluated 92 eyes from 92 adult cases of uncomplicated phacoemulsification and posterior chamber intraocular lens (IOL) implantation. The cases were divided into PEX, PEXG, POAG, and control groups. Serum samples were taken from the antecubital vein just before the surgery, and the AH samples were aspirated at the beginning of the surgery. Kruskal-Wallis H, One-way ANOVA, Mann-Whitney U with Bonferroni correction and Chi-Square tests were used for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The serum clusterin levels were the highest in the PEXG group, but no statistically significant differences were observed between the groups (<jats:italic>p<\/jats:italic>=0.633). The mean AH clusterin levels were 286.79\u00b129.64\u2009\u03bcg\/mL in the PEXG group, 263.92\u00b131.70\u2009\u03bcg\/mL in the PEX group, 272.59\u00b149.71\u2009\u03bcg\/mL in the POAG group, and 193.50\u00b162.38\u2009\u03bcg\/mL in the control group (<jats:italic>p<\/jats:italic>&lt;\u20090.001). This came out to be 1.48 times increase for the PEXG group, 1.36 for the PEX group, and 1.41 for the POAG group when compared with the control subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A higher level of clusterin in the anterior chamber was found to be associated with PEX and PEXG. In addition, a high level of anterior chamber clusterin in POAG, which is a new finding, showed that this molecule might be important not only in pseudoexfoliation, but also other types of glaucoma like POAG.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01781-7","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T12:14:07Z","timestamp":1610194447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of aqueous humor and serum clusterin levels in patients with glaucoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Fuat","family":"Yavrum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Elgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Adiyaman","family":"Kocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"Fidanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"issue":"3","key":"1781_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1781_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711\u201320.","journal-title":"Lancet."},{"issue":"4","key":"1781_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0039-6257(00)00196-X","volume":"45","author":"R Ritch","year":"2001","unstructured":"Ritch R, Schl\u00f6tzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265\u2013315.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1781_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/01.ijg.0000243470.13343.8b","volume":"16","author":"SM Jeng","year":"2007","unstructured":"Jeng SM, Karger RA, Hodge DO, Burke JP, Johnson DH, Good MS. The risk of glaucoma in pseudoexfoliation syndrome. J Glaucoma. 2007;16(1):117\u201321.","journal-title":"J Glaucoma"},{"issue":"5","key":"1781_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ajo.2006.01.047","volume":"141","author":"U Schl\u00f6tzer-Schrehardt","year":"2006","unstructured":"Schl\u00f6tzer-Schrehardt U, Naumann GO. Ocular and systemic Pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141(5):921\u201337.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1781_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1073\/pnas.90.2.725","volume":"90","author":"BJ Aronow","year":"1993","unstructured":"Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci U S A. 1993;90(2):725\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1781_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","volume":"34","author":"S Jones","year":"2002","unstructured":"Jones S. Clusterin. Int J Biochem Cell Biol. 2002;34(5):427\u201331.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1781_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0014-4835(05)80064-8","volume":"60","author":"DJ Reeder","year":"1995","unstructured":"Reeder DJ, Stuart WD, Witte DP, Brown TL, Harmony JA. Local synthesis of apolipoprotein J in the eye. Exp Eye Res. 1995;60(5):495\u2013504.","journal-title":"Exp Eye Res"},{"key":"1781_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/0-387-23226-5_14","volume":"38","author":"M Calero","year":"2005","unstructured":"Calero M, Rostagno A, Frangione B, Ghiso J. Clusterin and Alzheimer\u2019s disease. Subcell Biochem. 2005;38:273\u201398.","journal-title":"Subcell Biochem"},{"issue":"3","key":"1781_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","volume":"25","author":"MR Wilson","year":"2000","unstructured":"Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci. 2000;25(3):95\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"1781_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1523-1747.1999.00531.x","volume":"112","author":"I Viard","year":"1999","unstructured":"Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol. 1999;112(3):290\u20136.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1781_CR12","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.bpj.2010.06.044","volume":"99","author":"R Creasey","year":"2010","unstructured":"Creasey R, Sharma S, Craig JE, Gibson CT, Ebner A, Hinterdorfer P, et al. Detecting protein aggregates on untreated human tissue samples by atomic force microscopy recognition imaging. Biophys J. 2010;99(5):1660\u20137.","journal-title":"Biophys J"},{"issue":"4","key":"1781_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1167\/iovs.06-0411","volume":"48","author":"B Ovodenko","year":"2007","unstructured":"Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, Yang A, et al. Proteomic analysis of exfoliation deposits. Investig Opthalmology Vis Sci. 2007;48(4):1447.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"1781_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.exer.2014.07.005","volume":"127","author":"B Padhy","year":"2014","unstructured":"Padhy B, Nanda GG, Chowdhury M, Chowdhury M, Padhi D, Rao A, et al. Role of an extracellular chaperone, Clusterin in the pathogenesis of Pseudoexfoliation syndrome and Pseudoexfoliation glaucoma. Exp Eye Res. 2014;127:69\u201376.","journal-title":"Exp Eye Res"},{"issue":"4","key":"1781_CR15","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1167\/iovs.13-12941","volume":"55","author":"I Doudevski","year":"2014","unstructured":"Doudevski I, Rostagno A, Cowman M, Liebmann J, Ritch R, Ghiso J. Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sci. 2014;55(4):2491\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1781_CR16","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1167\/iovs.05-1580","volume":"47","author":"M Zenkel","year":"2006","unstructured":"Zenkel M, Kruse FE, J\u00fcnemann AG, Naumann GO, Schl\u00f6tzer-Schrehardt U. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. InvestOphthalmol Vis Sci. 2006;47(5):1982\u201390.","journal-title":"InvestOphthalmol Vis Sci"},{"key":"1781_CR17","first-page":"52","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish RK II, Anderson DR. Clinical decisions in glaucoma. St Louis: The CV Mosby Co; 1993. p. 52\u201361."},{"issue":"1","key":"1781_CR18","first-page":"50","volume":"6","author":"Z Yildirim","year":"2013","unstructured":"Yildirim Z, Yildirim F, U\u00e7gun NI, Sepici-Din\u00e7el A. The role of the cytokines in the pathogenesis of pseudoexfoliation syndrome. Int J Ophthalmol. 2013;6(1):50\u20133.","journal-title":"Int J Ophthalmol"},{"key":"1781_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/OPTH.S155168","volume":"12","author":"A Kondkar","year":"2018","unstructured":"Kondkar A, Azad TA, Almobarak F, Kalantan H, Al-Obeidan SA, Abu-Amero KK. Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma. Clin Ophthalmol. 2018;12:153\u20139.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1781_CR20","first-page":"823","volume":"11","author":"N Eraslan","year":"2018","unstructured":"Eraslan N, Elgin U, \u015een E, Kilic A, Yilmazbas P. Comparison of total\/active ghrelin levels in primary open angle glaucoma, pseudoexfoliation glaucoma and pseudoexfoliation syndrome. Int J Ophthalmol. 2018;11(5):823\u20137.","journal-title":"Int J Ophthalmol"},{"key":"1781_CR21","first-page":"1","volume":"29","author":"B Can Demirdogen","year":"2019","unstructured":"Can Demirdogen B, Demirkaya-Budak S, \u00d6zge G, Mumcuo\u011flu T. Evaluation of tear fluid and aqueous humor concentration of clusterin as biomarkers for early diagnosisof pseudoexfoliation syndrome and pseudoexfoliative glaucoma. Curr Eye Res. 2019;29:1\u20139.","journal-title":"Curr Eye Res"},{"issue":"2","key":"1781_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10384-016-0428-2","volume":"60","author":"M Nakamura-Shibasaki","year":"2016","unstructured":"Nakamura-Shibasaki M, Latief MA, Ko J, Funaishi K, Kiuchi Y. Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits. Jpn J Ophthalmol. 2016;60(2):95\u2013102.","journal-title":"Jpn J Ophthalmol"},{"key":"1781_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0079-6123(08)01138-2","volume":"173","author":"S Pucci","year":"2008","unstructured":"Pucci S, Mazzarelli P, Missiroli F, Regine F, Ricci F. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon. Prog Brain Res. 2008;173:555\u201373.","journal-title":"Prog Brain Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01781-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T21:11:45Z","timestamp":1610485905000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01781-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1781"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01781-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the institutional board of the Ankara Numune Training and Research Hospital ethics committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants provided written informed consent before participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}